Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production

Identifieur interne : 000243 ( France/Analysis ); précédent : 000242; suivant : 000244

Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production

Auteurs : Thomas G. Evans [États-Unis] ; Esper G. Kallas [États-Unis, Brésil] ; Meredith Campbell [États-Unis] ; Jolene Andrews [États-Unis] ; David Schwartz [États-Unis] ; Michael Keefer [États-Unis] ; Pierre Caudrelier [France]

Source :

RBID : ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77

English descriptors

Abstract

Abstract: CD8+ cytolytic activity is traditionally measured by detecting the release of 51Cr after incubation of effector cells with HLA-matched, infected, radiolabeled targets. An alternative method to detect CD8+ activity is to measure the production of intracellular interferon gamma (IFNγ) after antigen-specific stimulation, either by ELISPOT or by flow cytometry. Studies were performed in 19 volunteers enrolled in a phase 1 trial of candidate canarypox HIV-1 vaccines that encoded multiple HIV-1 genes. The vaccines including vCP205 (Env, Gag, and protease), vCP1433 (Env, Gag, protease, and CTL epitope-rich regions of pol and nef) and vCP1452 (equivalent to vCP1433 with additional immunomodulatory genes of vaccinia). PBMCs were stimulated in vitro with vaccinia constructs encoding env and gag or a lacZ control, and the effectors were cultured for 12–14 days. EBV-transformed B cell lines were infected overnight with the vaccinia vectors, and then incubated with the effector cells for 4 h in the presence of monensin. CD8+ gene-specific activity was determined as a percentage of IFNγ cells in the CD3+CD8+CD45RO+ gate after subtracting both the isotype control and the lacZ control stimulation. CD4 memory IFNγ production was simultaneously determined in the CD3+CD8−CD45RO+ gate. Using these techniques in blinded studies, we found that CD8+ IFNγ activity could be measured in the majority of volunteers given four immunizations. Specifically, the responses to the gag gene were control — 0/2; vCP205 — 2/4; vCP1433 — 5/6; vCP1452 — 4/7. Most of the positive responses were detected after the fourth immunization. Flow cytometric techniques hold promise as a surrogate measure of CTL and for ease of phenotyping of the effector population.

Url:
DOI: 10.1016/S0165-2478(01)00173-0


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production</title>
<author>
<name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
</author>
<author>
<name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
</author>
<author>
<name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
</author>
<author>
<name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
</author>
<author>
<name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
</author>
<author>
<name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
</author>
<author>
<name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0165-2478(01)00173-0</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-RFRLMXZ5-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000925</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000925</idno>
<idno type="wicri:Area/Istex/Curation">000925</idno>
<idno type="wicri:Area/Istex/Checkpoint">000E89</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000E89</idno>
<idno type="wicri:doubleKey">0165-2478:2001:Evans T:evaluation:of:canarypox</idno>
<idno type="wicri:Area/Main/Merge">003605</idno>
<idno type="wicri:Area/Main/Curation">003567</idno>
<idno type="wicri:Area/Main/Exploration">003567</idno>
<idno type="wicri:Area/France/Extraction">000243</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production</title>
<author>
<name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>1 Present address: Universidade Federal de São Paulo</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Johns Hopkins University, Sacramento, CA</wicri:regionArea>
<wicri:noRegion>CA</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Infectious Diseases Unit, Suite 500, Department of Medicine, University of Rochester School of Medicine and Dentistry, PSSB 4150 V St., Sacramento, CA 95817</wicri:regionArea>
<wicri:noRegion>CA 95817</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Aventis Pasteur, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Immunology Letters</title>
<title level="j" type="abbrev">IMLET</title>
<idno type="ISSN">0165-2478</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">77</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="7">7</biblScope>
<biblScope unit="page" to="15">15</biblScope>
</imprint>
<idno type="ISSN">0165-2478</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0165-2478</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Canarypox-induced CD8+ responses</term>
<term>Effector population</term>
<term>IFNγ production</term>
<term>Immunization</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Assay</term>
<term>Autologous</term>
<term>Becton dickinson immunocytometry systems</term>
<term>Blcl</term>
<term>Canarypox</term>
<term>Canarypox immunization</term>
<term>Cell lines</term>
<term>Cell responses</term>
<term>Chromium</term>
<term>Chromium release</term>
<term>Chromium release assay</term>
<term>Chromium release assays</term>
<term>Chromium release techniques</term>
<term>Cytokine</term>
<term>E6ans</term>
<term>Effector</term>
<term>Effector cells</term>
<term>Effector population</term>
<term>Elsevier science</term>
<term>Emmes corporation</term>
<term>Fourth immunization</term>
<term>Fourth vaccination</term>
<term>Gene product</term>
<term>Ifng</term>
<term>Immunization</term>
<term>Immunology</term>
<term>Immunology letters</term>
<term>Infg</term>
<term>Intracellular</term>
<term>Intracellular staining</term>
<term>Isotype</term>
<term>Isotype control</term>
<term>Isotype controls</term>
<term>Lymphocyte gate</term>
<term>Number positi6es</term>
<term>Overall response</term>
<term>Pbmcs</term>
<term>Peptide</term>
<term>Peptide pool</term>
<term>Permeabilization buffer</term>
<term>Positive assay</term>
<term>Positive assays</term>
<term>Rank order</term>
<term>Recombinant</term>
<term>Response rate</term>
<term>Response rates</term>
<term>Rochester aveu</term>
<term>Staining buffer</term>
<term>Tight gates</term>
<term>Unstained sample</term>
<term>Vaccination</term>
<term>Vaccine</term>
<term>Vaccine trial</term>
<term>Vaccinia</term>
<term>Vaccinia control</term>
<term>Vaccinia vectors</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: CD8+ cytolytic activity is traditionally measured by detecting the release of 51Cr after incubation of effector cells with HLA-matched, infected, radiolabeled targets. An alternative method to detect CD8+ activity is to measure the production of intracellular interferon gamma (IFNγ) after antigen-specific stimulation, either by ELISPOT or by flow cytometry. Studies were performed in 19 volunteers enrolled in a phase 1 trial of candidate canarypox HIV-1 vaccines that encoded multiple HIV-1 genes. The vaccines including vCP205 (Env, Gag, and protease), vCP1433 (Env, Gag, protease, and CTL epitope-rich regions of pol and nef) and vCP1452 (equivalent to vCP1433 with additional immunomodulatory genes of vaccinia). PBMCs were stimulated in vitro with vaccinia constructs encoding env and gag or a lacZ control, and the effectors were cultured for 12–14 days. EBV-transformed B cell lines were infected overnight with the vaccinia vectors, and then incubated with the effector cells for 4 h in the presence of monensin. CD8+ gene-specific activity was determined as a percentage of IFNγ cells in the CD3+CD8+CD45RO+ gate after subtracting both the isotype control and the lacZ control stimulation. CD4 memory IFNγ production was simultaneously determined in the CD3+CD8−CD45RO+ gate. Using these techniques in blinded studies, we found that CD8+ IFNγ activity could be measured in the majority of volunteers given four immunizations. Specifically, the responses to the gag gene were control — 0/2; vCP205 — 2/4; vCP1433 — 5/6; vCP1452 — 4/7. Most of the positive responses were detected after the fourth immunization. Flow cytometric techniques hold promise as a surrogate measure of CTL and for ease of phenotyping of the effector population.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Brésil</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Lyon</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
</noRegion>
<name sortKey="Andrews, Jolene" sort="Andrews, Jolene" uniqKey="Andrews J" first="Jolene" last="Andrews">Jolene Andrews</name>
<name sortKey="Campbell, Meredith" sort="Campbell, Meredith" uniqKey="Campbell M" first="Meredith" last="Campbell">Meredith Campbell</name>
<name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name>
<name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
<name sortKey="Keefer, Michael" sort="Keefer, Michael" uniqKey="Keefer M" first="Michael" last="Keefer">Michael Keefer</name>
<name sortKey="Schwartz, David" sort="Schwartz, David" uniqKey="Schwartz D" first="David" last="Schwartz">David Schwartz</name>
</country>
<country name="Brésil">
<noRegion>
<name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G." last="Kallas">Esper G. Kallas</name>
</noRegion>
</country>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Caudrelier, Pierre" sort="Caudrelier, Pierre" uniqKey="Caudrelier P" first="Pierre" last="Caudrelier">Pierre Caudrelier</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000243 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000243 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:65A64D2B74F2447A5B5798DCB3ED28295022CD77
   |texte=   Evaluation of canarypox-induced CD8+ responses following immunization by measuring the effector population IFNγ production
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021